New Zealand markets open in 2 hours 40 minutes

Jin Medical International Ltd. (ZJYL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.8600-0.1800 (-5.92%)
At close: 04:00PM EDT
2.8600 0.00 (0.00%)
After hours: 07:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 452.42M
Enterprise value 439.84M
Trailing P/E 144.50
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)21.16
Price/book (mrq)18.87
Enterprise value/revenue 22.19
Enterprise value/EBITDA 142.20

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3401.75%
S&P500 52-week change 326.24%
52-week high 325.4935
52-week low 30.4013
50-day moving average 33.2046
200-day moving average 33.7605

Share statistics

Avg vol (3-month) 3319.86k
Avg vol (10-day) 3334.75k
Shares outstanding 5156.55M
Implied shares outstanding 6162.29M
Float 837.82M
% held by insiders 175.84%
% held by institutions 10.50%
Shares short (15 May 2024) 41.3M
Short ratio (15 May 2024) 43.43
Short % of float (15 May 2024) 42.64%
Short % of shares outstanding (15 May 2024) 40.83%
Shares short (prior month 15 Apr 2024) 41.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 220:1
Last split date 308 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 14.52%
Operating margin (ttm)11.45%

Management effectiveness

Return on assets (ttm)6.66%
Return on equity (ttm)14.68%

Income statement

Revenue (ttm)19.82M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)-1.60%
Gross profit (ttm)N/A
EBITDA 3.09M
Net income avi to common (ttm)2.88M
Diluted EPS (ttm)0.0200
Quarterly earnings growth (yoy)-24.90%

Balance sheet

Total cash (mrq)16.7M
Total cash per share (mrq)0.11
Total debt (mrq)4.11M
Total debt/equity (mrq)17.15%
Current ratio (mrq)3.49
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)3.11M
Levered free cash flow (ttm)-1.57M